In this issue of Pediatric Blood & Cancer, Johnson et al. leveraged Surveillance, Epidemiology, and End Results (SEER)-Medicaid-linked data to examine (i) stage at diagnosis, and (ii) survival disparities in children diagnosed with cancer who were enrolled in Medicaid. 1 An additional and novel component to this study was the assessment of Medicaid coverage disruptions on delays in diagnosis and inferior survival outcomes. Not surprisingly, the authors demonstrated that children and adolescents enrolled in Medicaid are more likely to have a distant stage diagnosis and worse survival outcomes compared to children on private insurance. This is consistent with previous studies evaluating the impact of insurance coverage on outcomes among children with acute lymphoblastic leukemia and other cancers. 2-4 In fact, this